Skip to content

Correlation between PD-1 gene polymorphism and sPD-1 expression in type 1 diabetes mellitus

Correlation between PD-1 gene polymorphism and sPD-1 expression in type 1 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079096
Enrollment
Unknown
Registered
2023-12-25
Start date
2020-12-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1diabetes

Interventions

Type 1 diabetes:None
Healthy control group:None

Sponsors

Department of Endocrinology, Lianyungang Clinical College of Nanjing Medical University/The First People’s Hospital of Lianyungang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 85 Years

Inclusion criteria

Inclusion criteria: Definite T1D requires that at least one of the following is present: 1) age less than 10 yr at diagnosis; 2) positive pancreatic autoantibodies at any time (GAD-65, IA-2, ICA, or ZnT8) or positive anti-insulin autoantibody at diagnosis only (within 10 d of starting insulin); or 3) the presence of two or more of the following clinical indicators suggestive of T1D: a) age at diagnosis less than 40 yr; b) nonobese at diagnosis according to body mass index (95th percentile pediatric and 30 kg/m2 adult); c) diabetic ketoacidosis (DKA) at any time; d) plasma C-peptide level below 0.8 ng/ml (with blood glucose 80 mg/dl if available) at any time; and e) family history of T1D in a first-degree relative (parent, sibling, or child).

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1) Type 2 diabetes patients, special type diabetes patients; 2) Patients with other autoimmune diseases or malignant tumors; 3) Patients with mental illness who cannot cooperate with this study; 4) Reject patients from this study.

Design outcomes

Primary

MeasureTime frame
rs2227981;sPD-1;RS2227982;

Secondary

MeasureTime frame
HbA1c;FPG;IAA;GADA;IA-2A;TC;TC;HDL;LDL;ALT;AST;UA;SCR;

Countries

China

Contacts

Public ContactWang Guofeng

Department of Endocrinology, Lianyungang Clinical College of Nanjing Medical University/The First People’s Hos

wangguofengo@21cn.com+86 189 6132 7083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026